kynurenic acid has been researched along with Paralysis in 1 studies
Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.
Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakshi, R | 1 |
| Faden, AI | 1 |
1 other study available for kynurenic acid and Paralysis
| Article | Year |
|---|---|
Blockade of the glycine modulatory site of NMDA receptors modifies dynorphin-induced behavioral effects.
Topics: Animals; Dynorphins; Glycine; Indoles; Injections, Spinal; Kynurenic Acid; Male; Paralysis; Rats; Ra | 1990 |